Kenya buys banned drug from India ahead of virus mass tests

A box of Plaquenil, an anti-malaria drug hydroxychloroquine made by Sanofi. FILE PHOTO | NMG 

Kenya has joined the countries “repurposing” the antimalarial drug hydroxychloroquine for emergency use ahead of mass testing for Covid-19.

By JAMES KARIUKI
More by this Author

Summary

• Kenya has joined the countries “repurposing” the antimalarial drug hydroxychloroquine for emergency use ahead of mass testing for Covid-19.
• The country has ordered a one-off consignment of 379,000 tablets of the hydroxychloroquine from India just three weeks after the Asian nation partially lifted a ban on the export of the drug.
• The deal follows last week’s telephone conversation between Foreign Affairs secretary Raychelle Omamo and Indian External Affairs minister Subrahmanyam Jaishankar.

The country has ordered a one-off consignment of 379,000 tablets of the hydroxychloroquine from India just three weeks after the Asian nation partially lifted a ban on the export of the drug.

The deal follows last week’s telephone conversation between Foreign Affairs secretary Raychelle Omamo and Indian External Affairs minister Subrahmanyam Jaishankar.

“In keeping with excellent bilateral ties and as a special gesture, India has allowed one-time export of prohibited Hydroxychloroquine Sulphate USP 200 mg (379,000 tablets) to Kenya to support Government of Kenya in its fight against Covid-19 pandemic,” said a communique from the Indian government.

In early April, India partially lifted a ban on the exports of the malaria drug after President Donald Trump sought supplies for the US, which has topped the world’s Covid-19 casualties with more than million confirmed cases and more than 60,000 deaths. In Kenya where the first case of Covid-19 was reported on March 13 and the number of cases was 396 by on Thursday.

Hydroxychloroquine, which has been approved for Covid-19 treatment in Jordan, the US and France as well as China has been tested and found to strengthen cells in the respiratory tract where the coronavirus punctures and releases its genetic material.

Laboratory findings published by medRxiv, an online server for medical articles show the alkaline-based Hydroxychloroquine protects the cell from becoming acidic, an environment that enables coronaviruses to multiply

“The end result is the coronavirus is bumped out of cells and cannot infect them. (How azithromycin contributes to this process isn’t clear yet, but doctors suspect that it may quell the worst respiratory symptoms of Covid-19 by reducing inflammation caused by the viral infection in the lungs.),” it said.

Thursday, Ms Omamo and her India counterpart confirmed the arrival of the second tranche of essential drugs — HIV medicines worth $154 million — in Nairobi, a gift to Kenya by the Government of India.

“The first tranche of essential medicines, as part of India’s commitment to providing essential medicines to the people of Kenya, was delivered in July 2018,” said the statement, which added that India had also donated chlorine in the form of Calcium Hypochlorite for water treatment following a request from the Kenyan government.

While an India-based drug manufacturer has received export orders for Hydroxychloroquine Sulphate, the European Union regulator and the World Health Organisation say the science does not support the decision.

Currently, there is no known coronavirus vaccine or treatment for the Covid-19.